Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug

Manjula Sritharan, Veena C. Yeruva, Sivagamisundaram C. Sivasailappan, Sridevi Duggirala

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The catalase-peroxidase KatG of Mycobacterium tuberculosis plays a central role in the mechanism of action of the anti-tubercular drug isoniazid (INH). Like other bacterial catalases, mycobacterial catalase-peroxidases are dual active enzymes with both catalase and peroxidase activities in the same protein molecule. In our previous study, we showed that iron deprivation resulted in the loss of peroxidase activity in several non-pathogenic mycobacterial species. Here we extended the study to pathogenic mycobacteria and showed that the peroxidase activity, associated with iron-sufficient (4 μg Fe/ml) conditions of growth was responsible for INH activation. Upon iron deprivation (0.02 μg Fe/ml), peroxidase activity was abolished and there was no activation of INH, as demonstrated both by INH-mediated NBT reduction (spectrophotometrically and activity staining in gels) and by viability studies as assayed by the microplate Alamar Blue assay (MABA). In the viability assay, iron-sufficient M. tuberculosis, Mycobacterium bovis and Mycobacterium bovis BCG were susceptible to INH and iron-deficient organisms expressing negligible peroxidase survived high concentrations of the drug. It is well known that M. tuberculosis is sensitive to low concentrations of INH while the minimum inhibitory concentration of the drug is quite high for other mycobacteria, especially the non-pathogenic species. We showed this difference to be due to the specificity of the peroxidase for the drug. As withholding of iron is one of the host's mechanisms of controlling an invading pathogen, the implications of these observations on the efficacy of the anti-tubercular drug INH are discussed with reference to the iron status within the human host.

Original languageEnglish (US)
Pages (from-to)1357-1364
Number of pages8
JournalWorld Journal of Microbiology and Biotechnology
Volume22
Issue number12
DOIs
StatePublished - Dec 2006
Externally publishedYes

Fingerprint

Antitubercular Agents
isoniazid
Isoniazid
Mycobacterium
Peroxidase
peroxidase
Iron
iron
drugs
Catalase
catalase
Mycobacterium tuberculosis
Mycobacterium bovis
Pharmaceutical Preparations
Assays
Chemical activation
viability
Mycobacterium bovis BCG
Peroxidases
peroxidases

Keywords

  • Alamar Blue assay
  • Catalase-peroxidases
  • Iron
  • Isoniazid
  • Mycobacteria

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Plant Science
  • Biochemistry
  • Food Science
  • Microbiology
  • Biotechnology

Cite this

Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug. / Sritharan, Manjula; Yeruva, Veena C.; Sivasailappan, Sivagamisundaram C.; Duggirala, Sridevi.

In: World Journal of Microbiology and Biotechnology, Vol. 22, No. 12, 12.2006, p. 1357-1364.

Research output: Contribution to journalArticle

Sritharan, Manjula ; Yeruva, Veena C. ; Sivasailappan, Sivagamisundaram C. ; Duggirala, Sridevi. / Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug. In: World Journal of Microbiology and Biotechnology. 2006 ; Vol. 22, No. 12. pp. 1357-1364.
@article{589c96b3b8934004b2e94220646523c9,
title = "Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug",
abstract = "The catalase-peroxidase KatG of Mycobacterium tuberculosis plays a central role in the mechanism of action of the anti-tubercular drug isoniazid (INH). Like other bacterial catalases, mycobacterial catalase-peroxidases are dual active enzymes with both catalase and peroxidase activities in the same protein molecule. In our previous study, we showed that iron deprivation resulted in the loss of peroxidase activity in several non-pathogenic mycobacterial species. Here we extended the study to pathogenic mycobacteria and showed that the peroxidase activity, associated with iron-sufficient (4 μg Fe/ml) conditions of growth was responsible for INH activation. Upon iron deprivation (0.02 μg Fe/ml), peroxidase activity was abolished and there was no activation of INH, as demonstrated both by INH-mediated NBT reduction (spectrophotometrically and activity staining in gels) and by viability studies as assayed by the microplate Alamar Blue assay (MABA). In the viability assay, iron-sufficient M. tuberculosis, Mycobacterium bovis and Mycobacterium bovis BCG were susceptible to INH and iron-deficient organisms expressing negligible peroxidase survived high concentrations of the drug. It is well known that M. tuberculosis is sensitive to low concentrations of INH while the minimum inhibitory concentration of the drug is quite high for other mycobacteria, especially the non-pathogenic species. We showed this difference to be due to the specificity of the peroxidase for the drug. As withholding of iron is one of the host's mechanisms of controlling an invading pathogen, the implications of these observations on the efficacy of the anti-tubercular drug INH are discussed with reference to the iron status within the human host.",
keywords = "Alamar Blue assay, Catalase-peroxidases, Iron, Isoniazid, Mycobacteria",
author = "Manjula Sritharan and Yeruva, {Veena C.} and Sivasailappan, {Sivagamisundaram C.} and Sridevi Duggirala",
year = "2006",
month = "12",
doi = "10.1007/s11274-006-9183-8",
language = "English (US)",
volume = "22",
pages = "1357--1364",
journal = "Mircen Journal of Applied Microbiology and Biotechnology",
issn = "0265-0762",
publisher = "Springer Netherlands",
number = "12",

}

TY - JOUR

T1 - Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug

AU - Sritharan, Manjula

AU - Yeruva, Veena C.

AU - Sivasailappan, Sivagamisundaram C.

AU - Duggirala, Sridevi

PY - 2006/12

Y1 - 2006/12

N2 - The catalase-peroxidase KatG of Mycobacterium tuberculosis plays a central role in the mechanism of action of the anti-tubercular drug isoniazid (INH). Like other bacterial catalases, mycobacterial catalase-peroxidases are dual active enzymes with both catalase and peroxidase activities in the same protein molecule. In our previous study, we showed that iron deprivation resulted in the loss of peroxidase activity in several non-pathogenic mycobacterial species. Here we extended the study to pathogenic mycobacteria and showed that the peroxidase activity, associated with iron-sufficient (4 μg Fe/ml) conditions of growth was responsible for INH activation. Upon iron deprivation (0.02 μg Fe/ml), peroxidase activity was abolished and there was no activation of INH, as demonstrated both by INH-mediated NBT reduction (spectrophotometrically and activity staining in gels) and by viability studies as assayed by the microplate Alamar Blue assay (MABA). In the viability assay, iron-sufficient M. tuberculosis, Mycobacterium bovis and Mycobacterium bovis BCG were susceptible to INH and iron-deficient organisms expressing negligible peroxidase survived high concentrations of the drug. It is well known that M. tuberculosis is sensitive to low concentrations of INH while the minimum inhibitory concentration of the drug is quite high for other mycobacteria, especially the non-pathogenic species. We showed this difference to be due to the specificity of the peroxidase for the drug. As withholding of iron is one of the host's mechanisms of controlling an invading pathogen, the implications of these observations on the efficacy of the anti-tubercular drug INH are discussed with reference to the iron status within the human host.

AB - The catalase-peroxidase KatG of Mycobacterium tuberculosis plays a central role in the mechanism of action of the anti-tubercular drug isoniazid (INH). Like other bacterial catalases, mycobacterial catalase-peroxidases are dual active enzymes with both catalase and peroxidase activities in the same protein molecule. In our previous study, we showed that iron deprivation resulted in the loss of peroxidase activity in several non-pathogenic mycobacterial species. Here we extended the study to pathogenic mycobacteria and showed that the peroxidase activity, associated with iron-sufficient (4 μg Fe/ml) conditions of growth was responsible for INH activation. Upon iron deprivation (0.02 μg Fe/ml), peroxidase activity was abolished and there was no activation of INH, as demonstrated both by INH-mediated NBT reduction (spectrophotometrically and activity staining in gels) and by viability studies as assayed by the microplate Alamar Blue assay (MABA). In the viability assay, iron-sufficient M. tuberculosis, Mycobacterium bovis and Mycobacterium bovis BCG were susceptible to INH and iron-deficient organisms expressing negligible peroxidase survived high concentrations of the drug. It is well known that M. tuberculosis is sensitive to low concentrations of INH while the minimum inhibitory concentration of the drug is quite high for other mycobacteria, especially the non-pathogenic species. We showed this difference to be due to the specificity of the peroxidase for the drug. As withholding of iron is one of the host's mechanisms of controlling an invading pathogen, the implications of these observations on the efficacy of the anti-tubercular drug INH are discussed with reference to the iron status within the human host.

KW - Alamar Blue assay

KW - Catalase-peroxidases

KW - Iron

KW - Isoniazid

KW - Mycobacteria

UR - http://www.scopus.com/inward/record.url?scp=33748188139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748188139&partnerID=8YFLogxK

U2 - 10.1007/s11274-006-9183-8

DO - 10.1007/s11274-006-9183-8

M3 - Article

VL - 22

SP - 1357

EP - 1364

JO - Mircen Journal of Applied Microbiology and Biotechnology

JF - Mircen Journal of Applied Microbiology and Biotechnology

SN - 0265-0762

IS - 12

ER -